Optimising Drug Formulation

The SMi Group’s 3rd Annual Optimising Drug Formulation Conference aims to explore the key role of formulation throughout pharmaceutical development.

Solubility continues to remain a fundamental challenge for the industry and will be addressed with a targeted session.
A special focus will also be placed on the unique challenges in Biopharmaceutical drug formulation, as innovations of today will prove to be the next decade’s blockbusters.

With formulation playing such a key role in the makings of a successful product, partnership sourcing and management of collaborations will be explored in dedicated case-study presentations.
The conference aims to bring two days of superb case study presentations, exploring current research and development in the formulation field.

Confirmed Speakers Include:

• Dr Tomas Landh, Principal Scientist, Preformulation and Delivery, Novo Nordisk
• Dr Barbara Lueckel, Global Drug Delivery Evaluator, Roche
• Dr Thomas Backensfeld, Head, Global Pharmaceutical Development, Bayer Schering Pharma
• Dr Ingvar Ymén, Principal Scientist, Analytical Chemistry, AstraZeneca
• Dr David Cipolla, Director, Pharmaceutical Sciences, Aradigm
• Kevin Maynard, Development Director, Imprint Pharmaceuticals
• Dr Alyson Connor, Principal Scientist, Pharmaceutical Profiles
• Annabel Boardman, Market Development Manager, Colorcon

This successful annual event attracts Executives, Directors and Scientists working in the pharmaceutical and biotech industries within:

• Drug Formulation  - Research and Development
• Drug Delivery
• Business Development and Strategic Licensing
• Technology Development